|
Volumn 28, Issue 3, 2015, Pages 1055-1058
|
Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADJUVANT CHEMOTHERAPY;
ADOPTIVE IMMUNOTHERAPY;
ADULT;
ADVERSE EFFECTS;
BREAST NEOPLASMS;
CELL CULTURE;
CELLULAR IMMUNITY;
CYTOKINE INDUCED KILLER CELL;
DENDRITIC CELL;
FEMALE;
HUMAN;
IMMUNOLOGY;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
PROCEDURES;
PSYCHOLOGY;
QUALITY OF LIFE;
TIME;
TRANSPLANTATION;
TREATMENT OUTCOME;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CELLS, CULTURED;
CHEMOTHERAPY, ADJUVANT;
CYTOKINE-INDUCED KILLER CELLS;
DENDRITIC CELLS;
FEMALE;
HUMANS;
IMMUNITY, CELLULAR;
IMMUNOTHERAPY, ADOPTIVE;
MIDDLE AGED;
NEOPLASM METASTASIS;
QUALITY OF LIFE;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84940990114
PISSN: 1011601X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (19)
|
References (0)
|